Unknown

Dataset Information

Advances and considerations in AD tau-targeted immunotherapy.


ABSTRACT: The multifactorial and complex nature of Alzheimer's disease (AD) has made it difficult to identify therapeutic targets that are causally involved in the disease process. However, accumulating evidence from experimental and clinical studies that investigate the early disease process point towards the required role of tau in AD etiology. Importantly, a large number of studies investigate and characterize the plethora of pathological forms of tau protein involved in disease onset and propagation. Immunotherapy is one of the most clinical approaches anticipated to make a difference in the field of AD therapeutics. Tau -targeted immunotherapy is the new direction after the failure of amyloid beta (Aß)-targeted immunotherapy and the growing number of studies that highlight the Aß-independent di

SUBMITTER: Bittar A 

PROVIDER: S-EPMC6980703 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature